These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29915962)

  • 1. No side-effects of single intranasal oxytocin administration in middle childhood.
    Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants.
    Fewtrell MS; Loh KL; Blake A; Ridout DA; Hawdon J
    Arch Dis Child Fetal Neonatal Ed; 2006 May; 91(3):F169-74. PubMed ID: 16223754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.
    DeMayo MM; Song YJC; Hickie IB; Guastella AJ
    Paediatr Drugs; 2017 Oct; 19(5):391-410. PubMed ID: 28721467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
    Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
    Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Cognitive Bias Modification training and oxytocin administration on trust in maternal support: study protocol for a randomized controlled trial.
    Verhees MWFT; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; de Winter S; Bosmans G
    Trials; 2017 Jul; 18(1):326. PubMed ID: 28709470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency and efficacy of two methods of intranasal oxytocin application in dogs.
    Schaebs FS; Deschner T; Range F; Karl S; Marshall-Pescini S
    Domest Anim Endocrinol; 2020 Jul; 72():106436. PubMed ID: 32114215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.
    MacDonald E; Dadds MR; Brennan JL; Williams K; Levy F; Cauchi AJ
    Psychoneuroendocrinology; 2011 Sep; 36(8):1114-26. PubMed ID: 21429671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nasal oxytocin on pregnancy rates following intrauterine insemination: double-blind, randomized, clinical pilot study.
    Ochsenkühn R; Pavlik R; Hecht S; von Schönfeldt V; Rogenhofer N; Thaler CJ
    Arch Gynecol Obstet; 2010 Apr; 281(4):753-9. PubMed ID: 19921230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
    Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
    J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.
    Cai Q; Feng L; Yap KZ
    Psychiatry Clin Neurosci; 2018 Mar; 72(3):140-151. PubMed ID: 29232031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
    Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
    Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W; Sher E; Gawchik S; Fineman S
    Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research.
    Guastella AJ; Hickie IB; McGuinness MM; Otis M; Woods EA; Disinger HM; Chan HK; Chen TF; Banati RB
    Psychoneuroendocrinology; 2013 May; 38(5):612-25. PubMed ID: 23265311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary levels of oxytocin remain elevated for more than two hours after intranasal oxytocin administration.
    Huffmeijer R; Alink LR; Tops M; Grewen KM; Light KC; Bakermans-Kranenburg MJ; Ijzendoorn MH
    Neuro Endocrinol Lett; 2012; 33(1):21-5. PubMed ID: 22467107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.
    Quintana DS; Westlye LT; Smerud KT; Mahmoud RA; Andreassen OA; Djupesland PG
    Horm Behav; 2018 Jun; 102():85-92. PubMed ID: 29750971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin nasal spray in fibromyalgic patients.
    Mameli S; Pisanu GM; Sardo S; Marchi A; Pili A; Carboni M; Minerba L; Trincas G; Carta MG; Melis MR; Agabio R
    Rheumatol Int; 2014 Aug; 34(8):1047-52. PubMed ID: 24509894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.
    Rash JA; Campbell TS
    Psychosom Med; 2014; 76(6):422-9. PubMed ID: 24979580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.